Published in Am J Psychiatry on January 01, 2004
Complex systems and the technology of variability analysis. Crit Care (2004) 2.24
Feedback of end-tidal pCO2 as a therapeutic approach for panic disorder. J Psychiatr Res (2007) 1.05
Characterization of affective states by pupillary dynamics and autonomic correlates. Front Neuroeng (2013) 0.87
Vagal-dependent nonlinear variability in the respiratory pattern of anesthetized, spontaneously breathing rats. J Appl Physiol (1985) (2011) 0.86
Coping skills and exposure therapy in panic disorder and agoraphobia: latest advances and future directions. Behav Ther (2011) 0.85
Vestibular testing in patients with panic disorder and chronic dizziness. Acta Otorhinolaryngol Ital (2007) 0.84
The Analysis of the Influence of Odorant's Complexity on Fractal Dynamics of Human Respiration. Sci Rep (2016) 0.77
Dynamic trajectory of multiple single-unit activity during working memory task in rats. Front Comput Neurosci (2015) 0.75
Cerebral and neural regulation of cardiovascular activity during mental stress. Biomed Eng Online (2016) 0.75
Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab (2007) 2.33
Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. Am J Physiol Endocrinol Metab (2004) 2.04
The oral glucose minimal model: estimation of insulin sensitivity from a meal test. IEEE Trans Biomed Eng (2002) 1.88
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
Frontal lobe dysfunction in pathological gambling patients. Biol Psychiatry (2002) 1.65
Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation (2003) 1.63
Insulin sensitivity by oral glucose minimal models: validation against clamp. Am J Physiol Endocrinol Metab (2005) 1.50
Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy. Diabetes Care (2007) 1.34
Measurement of selective effect of insulin on glucose disposal from labeled glucose oral test minimal model. Am J Physiol Endocrinol Metab (2005) 1.25
Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet (2004) 1.20
Understanding obsessive-compulsive disorder: focus on decision making. Neuropsychol Rev (2006) 1.14
Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet (2005) 1.13
Executive dysfunctions in obsessive-compulsive patients and unaffected relatives: searching for a new intermediate phenotype. Biol Psychiatry (2010) 1.11
Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study. Biol Psychiatry (2003) 1.09
In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. Neuroimage (2008) 1.08
Neuropsychological investigation of decision-making in anorexia nervosa. Psychiatry Res (2004) 1.08
Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet (2002) 1.07
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Eur Neuropsychopharmacol (2005) 1.07
Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review. Hum Psychopharmacol (2007) 1.01
Regulation of endogenous glucose production after a mixed meal in type 2 diabetes. Am J Physiol Endocrinol Metab (2002) 0.99
Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Clin Psychiatry (2007) 0.97
Resilience to transformation and inherent genetic and functional stability of adult neural stem cells ex vivo. Cancer Res (2007) 0.96
Obsessive compulsive disorder among idiopathic focal dystonia patients: an epidemiological and family study. Biol Psychiatry (2002) 0.95
Clonazepam in the treatment of psychiatric disorders: an update. Int Clin Psychopharmacol (2006) 0.95
Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors D2 partial agonist aripiprazole. Recent Pat Endocr Metab Immune Drug Discov (2014) 0.94
Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects. Am J Physiol Endocrinol Metab (2003) 0.94
The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice. Int J Mol Sci (2013) 0.92
Present and lifetime comorbidity of tobacco, alcohol and drug use in eating disorders: a European multicenter study. Drug Alcohol Depend (2008) 0.91
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90
Panic disorder respiratory subtype: psychopathology, laboratory challenge tests, and response to treatment. Harv Rev Psychiatry (2010) 0.89
Self-injurious behavior and attempted suicide in purging bulimia nervosa: associations with psychiatric comorbidity. J Affect Disord (2007) 0.89
Executive functioning in anorexia nervosa patients and their unaffected relatives. Psychiatry Res (2012) 0.88
Low social interactions in eating disorder patients in childhood and adulthood: a multi-centre European case control study. J Health Psychol (2012) 0.88
Fat mass and obesity-associated gene (FTO) in eating disorders: evidence for association of the rs9939609 obesity risk allele with bulimia nervosa and anorexia nervosa. Obes Facts (2012) 0.87
Freezing reaction in panic disorder patients associated with anticipatory anxiety. Depress Anxiety (2009) 0.87
Neurosteroid secretion in panic disorder. Psychiatry Res (2003) 0.87
Investigation of the serotonin transporter regulatory region polymorphism in bulimia nervosa: relationships to harm avoidance, nutritional parameters, and psychiatric comorbidity. Psychosom Med (2006) 0.87
A new dynamic index of insulin sensitivity. IEEE Trans Biomed Eng (2006) 0.87
Smoking and respiratory irregularity in panic disorder. Biol Psychiatry (2004) 0.87
Thermal imaging of exercise-associated skin temperature changes in trained and untrained female subjects. Ann Biomed Eng (2012) 0.86
Generalization of map estimation in SAAM II: validation against ADAPT II in a glucose model case study. Ann Biomed Eng (2002) 0.86
Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome. J Clin Psychopharmacol (2002) 0.86
Decision-making functioning as a predictor of treatment outcome in anorexia nervosa. Psychiatry Res (2006) 0.86
Motor inhibition and cognitive flexibility in eating disorder subtypes. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.85
Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacology (2005) 0.85
Genetic polymorphisms of the enzymes involved in DNA methylation and synthesis in elite athletes. Physiol Genomics (2011) 0.85
Chronotype influences activity circadian rhythm and sleep: differences in sleep quality between weekdays and weekend. Chronobiol Int (2014) 0.84
Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients. Neuropsychopharmacology (2006) 0.84
Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. Int Clin Psychopharmacol (2009) 0.83
Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: assessment during physiological glucose and insulin concentrations. Am J Physiol Gastrointest Liver Physiol (2005) 0.82
Artificial neural network model for the prediction of obsessive-compulsive disorder treatment response. J Clin Psychopharmacol (2009) 0.82
Bayesian two-compartment and classic single-compartment minimal models: comparison on insulin modified IVGTT and effect of experiment reduction. IEEE Trans Biomed Eng (2003) 0.82
Novel antidepressants and panic disorder: evidence beyond current guidelines. Neuropsychobiology (2010) 0.81
Efficacy and safety of long acting injectable atypical antipsychotics: a review. Curr Clin Pharmacol (2013) 0.81
Respiration in children at risk for panic disorder. Arch Gen Psychiatry (2002) 0.81
Switching to unboosted atazanavir improves glucose tolerance in highly pretreated HIV-1 infected subjects. Eur J Endocrinol (2007) 0.81
Fasting blood sample-based assessment of insulin sensitivity in kidney-pancreas-transplanted patients. Diabetes Care (2002) 0.81
Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy. Diabetes Care (2003) 0.81
Anticipation of age at onset of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder. Psychiatry Res (2002) 0.81
Cardiorespiratory response to physical exercise and psychological variables in panic disorder. Rev Bras Psiquiatr (2011) 0.80
Case-control and combined family trios analysis of three polymorphisms in the ghrelin gene in European patients with anorexia and bulimia nervosa. Psychiatr Genet (2006) 0.80
Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis. Eur J Endocrinol (2006) 0.79
Effects of cigarette smoking on neuropsychological performance in mood disorders: a comparison between smoking and nonsmoking inpatients. J Clin Psychiatry (2013) 0.79
Dynamic insulin sensitivity index: importance in diabetes. Am J Physiol Endocrinol Metab (2009) 0.79
The somatic marker affecting decisional processes in obsessive-compulsive disorder. Cogn Neuropsychiatry (2011) 0.79
S-Adenosyl-L-Methionine augmentation in patients with stage II treatment-resistant major depressive disorder: an open label, fixed dose, single-blind study. ScientificWorldJournal (2013) 0.78
Nonhepatic glucose production in humans. Am J Physiol Endocrinol Metab (2003) 0.78
Baseline respiratory parameters in panic disorder: a meta-analysis. J Affect Disord (2012) 0.78
The Relationships between Cholesterol and Suicide: An Update. ISRN Psychiatry (2012) 0.78
Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency. Thyroid (2008) 0.78
[Antidepressant drugs and breastfeeding]. Recenti Prog Med (2007) 0.78
Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study. J Clin Psychopharmacol (2004) 0.78
No association between obsessive-compulsive disorder and the 5-HT(1Dbeta) receptor gene. Am J Psychiatry (2002) 0.78
Anxiety sensitivity and 35% CO2 reactivity in patients with panic disorder. J Psychosom Res (2003) 0.77
Amino acid kinetics during the anhepatic phase of liver transplantation. Diabetes (2002) 0.77
The advantages of choosing antiobsessive therapy according to decision-making functioning. J Clin Psychopharmacol (2004) 0.77
Are respiratory abnormalities specific for panic disorder? A meta-analysis. Neuropsychobiology (2014) 0.77
Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)-deficient adult patients and is not improved after short-term GH replacement therapy. Clin Endocrinol (Oxf) (2012) 0.77
Serotonergic modulation of the balance system in panic disorder: an open study. Depress Anxiety (2003) 0.77
Anxiety sensitivity and modulation of the serotonergic system in patients with PD. J Anxiety Disord (2004) 0.77
Panic and the brainstem: clues from neuroimaging studies. CNS Neurol Disord Drug Targets (2014) 0.76
Comparison of 35% carbon dioxide reactivity between panic disorder and eating disorder. Psychiatry Res (2004) 0.76
Selective serotonin re-uptake inhibitors beyond psychiatry: are they useful in the treatment of severe, chronic, obstructive pulmonary disease? Depress Anxiety (2004) 0.76
Acoustic startle response in panic disorder. Psychiatry Res (2010) 0.76
Lack of relationship between CO2 reactivity and serotonin transporter gene regulatory region polymorphism in panic disorder. Am J Med Genet B Neuropsychiatr Genet (2004) 0.76
Is there a hypersensitive visual alarm system in panic disorder? Psychiatry Res (2010) 0.76
Novel 5'-regulatory region polymorphisms of the 5-HT2C receptor gene: association study with panic disorder. Int J Neuropsychopharmacol (2000) 0.76
Alexithymia, Suicide Ideation, C-Reactive Protein, and Serum Lipid Levels Among Outpatients with Generalized Anxiety Disorder. Arch Suicide Res (2015) 0.76
Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature. Expert Opin Pharmacother (2010) 0.76
Supporting tools in psychiatric treatment decision-making: sertraline outcome investigation with artificial neural network method. Psychiatry Res (2005) 0.76